Trial Profile
Randomized, Double-blind, Placebo-controlled Trial of Z-100 Plus Radiation Therapy in Patients With Locally Advanced Cervical Cancer — A Phase III Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Mar 2022
Price :
$35
*
At a glance
- Drugs Z 100 (Primary)
- Indications Cervical cancer; Squamous cell cancer
- Focus Registrational; Therapeutic Use
- Sponsors Zeria
- 03 Mar 2022 Status changed from active, no longer recruiting to completed.
- 08 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 04 Jun 2018 Planned number of patients changed from 600 to 780.